Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
723 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Changsha, Chengdu
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - No phaseTaking peopleSilent Evaluation of DeepTRG for Assessing Tumor Response After Preoperative Treatment in Stomach and Gastroesophageal Junction Cancer
- Where
- Shijiazhuang
- Életkor
- 18 év and over
- People
- 200
- Run by
- Qun Zhao
See details and how to joinNCT07849608 - No phaseTaking peopleA Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)
- Where
- Guangdong
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Jie Yuan,MD
See details and how to joinNCT07850882 - 3. fázisTaking peoplePhase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
- Where
- Beijing, Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Akeso
See details and how to joinNCT07700979 - 3. fázisTaking peopleStudy of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 416
- Run by
- Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT04415853 - No phaseTaking peopleThe Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Peking University First Hospital
See details and how to joinNCT07039474 - 1/2. fázisTaking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Beijing, Shandong
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Changsha, Chongqing, Guangzhou, Hangzhou, Hefei, Shanghai, Shenyang, Wuhan, Xi'an, Zhengzhou
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 3. fázisTaking peopleA Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 555
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT07315750 - No phaseTaking peopleImage-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 36
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07835087 - 2. fázisNot yet taking people in KínaA Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 34
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07828873 - No phaseNot yet taking people in KínaSafety and Efficacy Evaluation of Single-Port Versus Multi-Port Robotic-Assisted Radical Distal Gastrectomy for Gastric Cancer
- Where
- Beijing, Chongqing, Jinan, Shijiazhuang, Wenzhou
- Életkor
- 18 év to 85 év
- People
- 212
- Run by
- First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07828899 - No phaseTaking peoplePredicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 120
- Run by
- Ruijin Hospital
See details and how to joinNCT07824479 - 1/2. fázisTaking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Lishui, Nanchang, Nanning, Shijiazhuang, Wenzhou, Wuhan, Xuzhou
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - No phaseNot yet taking people in KínaRisk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 100
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07822906 - 2. fázisNot yet taking people in KínaNeoadjuvant Sacituzumab Tirumotecan Plus Toripalimab in Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Shijiazhuang
- Életkor
- 18 év and over
- People
- 33
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07823270 - 2. fázisTaking peopleFirst-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
- Where
- Binzhou, Dongying, Jinan, Jining, Liaocheng, Linyi, Qingdao, Taian, Tengzhou, Weifang, Yantai, Zhengzhou, Zibo
- Életkor
- 18 év to 75 év
- People
- 110
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06730373 - 1/2. fázisTaking peopleClinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
- Where
- Anyang, Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangxi, Harbin, Hefei, Jiaozuo, Lanzhou, Liyi, Luoyang, Luzhou, Nanjing, Nanning, Shanghai, Shantou, Taiyuan, Tianjin, Wenzhou, Xi’an, Yangzhou, Zhengzhou, Zunyi
- Életkor
- 18 év to 75 év
- People
- 105
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07367516 - 1. fázisTaking peopleNKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- Peking University
See details and how to joinNCT06134960 - No phaseTaking peopleLaparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer
- Where
- Ch’ang-ch’un, Changchun
- People
- 36
- Run by
- Jilin University
See details and how to joinNCT07615374 - 2. fázisNot yet taking people in KínaTrastuzumab Combined With Retlirafusp Alfa in Treating HER2(Human Epidermal Growth Factor Receptor 2) 2+/3+ Gastric/Gastroesophageal Junction Adenocarcinoma After First-line Systemic Therapy Failure
- Where
- Zhengzhou
- Életkor
- 18 év and over
- People
- 35
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07817654 - 1. fázisTaking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Guangzhou, Hangzhou, Shanghai, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - 2. fázisTaking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jining, Kunming, Nanchang, Nanjing, Nanning, Shandong, Shanghai, Shenyang, Tianjin, Wuhan, Wuhou District, Zhengzhou
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - 2. fázisTaking peopleSacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 28
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07811752 - 2. fázisTaking peopleApatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
- Where
- Bengbu
- Életkor
- 65 év and over
- People
- 30
- Run by
- The First Affiliated Hospital of Bengbu Medical University
See details and how to joinNCT03219593